IT1169837B - Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello - Google Patents

Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello

Info

Publication number
IT1169837B
IT1169837B IT22949/83A IT2294983A IT1169837B IT 1169837 B IT1169837 B IT 1169837B IT 22949/83 A IT22949/83 A IT 22949/83A IT 2294983 A IT2294983 A IT 2294983A IT 1169837 B IT1169837 B IT 1169837B
Authority
IT
Italy
Prior art keywords
brain
improvement
treatment
pharmaceutical composition
composition useful
Prior art date
Application number
IT22949/83A
Other languages
English (en)
Other versions
IT8322949A0 (it
Inventor
Shizuo Kuriyama
Saitoh Mikio
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IT8322949A0 publication Critical patent/IT8322949A0/it
Application granted granted Critical
Publication of IT1169837B publication Critical patent/IT1169837B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT22949/83A 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello IT1169837B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (2)

Publication Number Publication Date
IT8322949A0 IT8322949A0 (it) 1983-09-21
IT1169837B true IT1169837B (it) 1987-06-03

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22949/83A IT1169837B (it) 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello

Country Status (5)

Country Link
US (2) US4507322A (it)
EP (1) EP0103897B1 (it)
JP (1) JPS5955829A (it)
DE (1) DE3369640D1 (it)
IT (1) IT1169837B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 2−(4−メチルアミノブトキシ)ジフェニルメタン・塩酸塩の製造方法
US5869536A (en) 1994-07-12 1999-02-09 Mitsubishi Chemical Corporation Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154070C (da) * 1975-06-19 1989-02-27 Mitsubishi Chem Ind Analogifremgangsmaade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 2―(ω‐アミノアルコキシ)ジフエニルメタン類

Also Published As

Publication number Publication date
JPH0233689B2 (it) 1990-07-30
IT8322949A0 (it) 1983-09-21
EP0103897B1 (en) 1987-02-04
EP0103897A1 (en) 1984-03-28
US4576966A (en) 1986-03-18
JPS5955829A (ja) 1984-03-31
DE3369640D1 (en) 1987-03-12
US4507322A (en) 1985-03-26

Similar Documents

Publication Publication Date Title
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT9020055A0 (it) Metodo per il mascheramento del sapore di farmaci
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ATE47035T1 (de) Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.
IT1179067B (it) Composto e composizione farmaceutica per il trattamento della osteoporosi
IT1213141B (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
IT1169837B (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
IT1212137B (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
MX9307679A (es) Derivados de furanona utiles en terapia.
DK163245C (da) Middel til behandling af neurologiske forstyrrelser eller lidelser
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice
IT8068350A0 (it) Composizione farmaceutica per il trattamento di malattie microvasco lari
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
ITMI930966A0 (it) Composizioni farmaceutiche per il trattamento della psoriasi
IT1152189B (it) Composizione farmaceutica per il trattamento della dermatite seborroica
RO92740A2 (ro) Compozitie medicamentoasa pentru tratamentul otitelor
IT8648164A0 (it) Composizione farmaceutica per il trattamento della cellulite

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929